An orally bioavailable Chk1 inhibitor, CCT244747, sensitizes bladder and head and neck cancer cell lines to radiation
| Image |  |
|---|---|
| Description | scientific article published on 25 January 2017 |
| Author/s | |
| Publication date | January 25, 2017 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |